Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study

Overview of attention for article published in Targeted Oncology, July 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 297 followers.

Nintedanib + Docetaxel in Patients with Advanced Lung Adenocarcinoma: Analyses of the Phase III LUME-Lung 1 Study https://t.co/cCnKLxwc77

Reply Repost Favourite